scholarly journals Prognostic Role of ABO Blood Type in Operable Esophageal Cancer: Analysis of 2179 Southern Chinese Patients

2020 ◽  
Vol 10 ◽  
Author(s):  
Shuishen Zhang ◽  
Minghan Jia ◽  
Xiaoli Cai ◽  
Weixiong Yang ◽  
Shufen Liao ◽  
...  
Keyword(s):  
Blood Group ◽  
Disease Free Survival ◽  
Blood Type ◽  
Chinese Patients ◽  
Abo Blood Group ◽  
Prognostic Impact ◽  
Type B ◽  
Blood Types ◽  
Southern Chinese ◽  
Abo Blood Type

BackgroundThe prognostic value of ABO blood types is not well clarified for esophageal carcinoma (EC). This study attempted to elucidate the associations between different ABO blood types and disease-free survival (DFS) and overall survival (OS) of EC.MethodsThis study was a retrospective review of the records of 2179 patients with EC who received surgery from December 2000 to December 2008. The prognostic impact of ABO blood group on DFS and OS were estimated using the Kaplan-Meier method and cox proportional hazard models.ResultsUnivariate analyses found significant differences in DFS and OS among the four blood types. Multivariate analyses showed ABO blood type independently predicted DFS (P=0.001) and OS (P=0.002). Furthermore, patients with non-B blood types had a significantly shorter DFS (HR=1.22, 95%CI:1.07–1.38, P=0.002) and OS (HR=1.22, 95%CI:1.07–1.38, P=0.003) than patients with blood type B, and patients with non-O blood types had a significantly better DFS (HR=0.86, 95%CI:0.77–0.96, P=0.006) and OS (HR=0.86, 95%CI:0.77–0.96, P=0.007) than patients with blood type O. Subgroup analyses found that blood type B had a better DFS and OS than non-B in patients who were male, younger, early pathological stages and had squamous-cell carcinomas (ESCC). Blood type O had a worse DFS and OS than non-O in patients who were male, younger, and had ESCC (P<0.05).ConclusionsThe results demonstrate that ABO blood group is an independent prognostic factor of survival, and that type B predicts a favorable prognosis, whereas type O predicts an unfavorable prognosis for survival in patients with EC, especially those with ESCC.

ABO blood group and the risk of breast cancer: Multicenter, case-control, observational study.

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. 1572-1572
Author(s):  
Yuksel Urun ◽  
Tulay Koru-Sengul ◽  
Kadri Altundag ◽  
Gungor Utkan ◽  
Handan Onur ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Prognostic Factors ◽  
Blood Group ◽  
Blood Groups ◽  
Blood Type ◽  
Abo Blood Group ◽  
Abo Blood Groups ◽  
Blood Types ◽  
Abo Blood Type

1572 Background: The role of genetic factors in the development of cancer is widely accepted. ABO blood type is an inherited characteristic and previous studies have observed an association between ABO blood group and risk of certain malignancies, including pancreatic and gastric cancer. The data on the role of ABO blood group and Rh factor in breast cancer is inconclusive. Methods: All patients who had breast cancer (BC) and treated between 2000-2010 at the Departments of Medical Oncology of both Ankara and Hacettepe Universities (Ankara, Turkey) with defined ABO blood type and Rh factor were included in our retrospective reviews of tumor registry records. A group of volunteer healthy women donors of Turkish Red Crescent between 2004-2011 were identified as a control group, without any matching factors. The relationship of ABO blood types and Rh factor with various prognostic factors such as age at diagnosis, menopausal status, family history of breast cancer, and ER/PR/HER2 status were evaluated from 1740 BC patients. We compared the distributions of ABO blood types, Rh factors among 1740 patients and 204,553 healthy controls. Among BC patients, differences between each of aforementioned ABO blood groups and Rh factors with respect to various prognostic factors were explored, respectively. Results: Overall distributions of ABO blood groups as well as Rh factor were comparable between patients (44% A, 8% AB, 16% B, 32% O, 88% Rh+) and controls (41% A, 8% AB, 16% B, 35% O, 87% Rh+). However, there were statistically significant differences between patients and controls with respect to A vs. nonA (p=0.019) and marginal significance (p=0.051) for O vs. nonO. Among patients, there were statistically significant differences between A and nonA with respect to HER2 (p=0.0421), M stage (p=0.0447), T stage (p=0.0020). Only T stage (p=0.0337) were significantly different between O vs nonO. Grade (p=0.0227) and M stage (p=0.0107) were significantly different between Rh factors. Conclusions: In our study sample, ABO blood type was statistically significantly associated with breast cancer. Additional studies are necessary to determine the mechanisms by which ABO blood type may influence the risk of breast cancer.

scholarly journals Distribution of ABO blood group in children with acute leukemias

2012 ◽  
Vol 2 (3) ◽  
pp. 220-223
Author(s):  
Meliha Sakić
Keyword(s):  
Acute Leukemia ◽  
Blood Group ◽  
Blood Type ◽  
Abo Blood Group ◽  
Type B ◽  
Acute Leukemias ◽  
Blood Types ◽  
Number Of Children ◽  
Pediatric Clinic ◽  
Type Ab

Introduction: This study is the fi rst study about the distribution ABO blood types at children with acute leukemia in Federation of Bosnia and Herzegovina. The aim of the study is to point out distribution of blood type groups at children with acute leukemia (AL)Methods: The number of children in this study was the following: 145 children with acute leukemia and 27 of children with acute myeloblastic leukemia (AML). All of the children were treated at Hemato- Oncology Unitof Pediatric Clinic in Sarajevo, in the period January 2000 until December 2010. Age of children was between 1 month and 15 years.Results: The results showed that different blood types were registered in 93. 1% of children who got ill and treated from acute leukemia for the mentioned period. At 6. 9 % of children, none of the blood types wereregistered. It was noticed that 40.9 % children who have registered blood type O, 37% blood type A,16% blood type B and 6.5% blood type AB had AL, too. It has been observed that children with following bloodtypes had AML: O, 47.8%, A, 47.7% and AB, 30.4%.Conclusion: Signifi cance ABO types distribution was confi rmed for children with ALL, p<0, 05. The analysis of the distribution of ABO types based on gender showed that signifi cance was confi rmed at females with both ALL and AML (p<0.05).

scholarly journals EFFECT OF MATERNAL ABO BLOOD TYPE ON BIRTH WEIGHT

2021 ◽  
pp. 183-186
Author(s):  
Dr.Himanshu S Dave ◽  
Dr.Tanushree Joshi ◽  
Dr.Kathakali Das ◽  
Dr.Dimple Pal
Keyword(s):  
Birth Weight ◽  
Low Birth Weight ◽  
Blood Group ◽  
Pregnancy Outcomes ◽  
Adverse Pregnancy Outcomes ◽  
Blood Type ◽  
Abo Blood Group ◽  
Type B ◽  
Abo Blood Type ◽  
Adverse Pregnancy

Background: ABO blood group has been recognized as a risk factor for distinct disease states. The association between ABO blood group and adverse pregnancy outcomes has not been extensively studied, especially in relation to birth weight. The aim of the present study is to determine whether ABO blood group contributes to the adverse pregnancy outcomes like low birth weight. Methods: Medical data including ABO phenotypes were collected from hospital database and retrospectively reviewed. Adverse pregnancy outcome studied was low birth weight. Birth week was also noted for each subject. Results: 500 charts of mothers who had given birth in our hospital were studied. Overall 146 (29.2%) women had type O blood, 108 (21.6%) had type A blood, 194 (38.8%) had type B blood and 52 (10.4%) had type AB blood. Pregnant women with type B blood group had significantly lower birth weights compared with type O, A and AB. Birth weeks of all groups were found to be similar with no statistically significant difference Conclusions: Maternal ABO phenotype is associated with low birth weight, while no association was found between blood type and birth week. We postulate that maternal/fetal immune system genes which are directly associated with ABO blood groups could affect pregnant with a resulting birth weight alterations. KEYWORDS: ABO blood type, Birth weight, Pregnancy.

scholarly journals Effect of maternal ABO blood type on birth weight and preeclampsia

2017 ◽  
Vol 6 (6) ◽  
pp. 2164 ◽  
Author(s):  
Fatma Beyazıt ◽  
Eren Pek ◽  
Aysenur Çakır Güngör ◽  
Meryem Gencer ◽  
Mesut A. Unsal
Keyword(s):  
Birth Weight ◽  
Low Birth Weight ◽  
Blood Group ◽  
Pregnancy Outcomes ◽  
Adverse Pregnancy Outcomes ◽  
Blood Type ◽  
Abo Blood Group ◽  
Abo Blood Groups ◽  
Type B ◽  
Adverse Pregnancy

Background: ABO blood group has been recognized as a risk factor for distinct disease states. The association between ABO blood group and adverse pregnancy outcomes has not been extensively studied, especially in relation to birth weight and preeclampsia (PE). The aim of the present study is to determine whether ABO blood group contributes to the adverse pregnancy outcomes including low birth weight and PE.Methods: Medical data including ABO phenotypes were collected from hospital electronic database and retrospectively reviewed. Adverse pregnancy outcomes included PE and low birth weight. Birth week was also noted for each subject.Results: 2177 charts of mothers who had given birth in our hospital were studied. Overall 605 (27.8%) women had type O blood, 1056 (48.5%) had type A blood, 369 (16.9%) had type B blood and 147 (6.8%) had type AB blood. Pregnant women with type B blood group had significantly lower birth weights compared with type O, A and AB. Birth weeks of all groups were found to be similar with no statistically significant difference. A total of 167 mothers were recorded as having PE. No association was observed between PE and ABO blood groups of study participants.Conclusions: Although maternal ABO phenotype is associated with low birth weight, no association was found between blood type and preeclampsia. We postulate that maternal/fetal immune system genes which are directly associated with ABO blood groups could affect pregnant with a resulting birth weight alterations.

scholarly journals Frequencies of feline blood types in Hungary

2001 ◽  
Vol 49 (4) ◽  
pp. 369-375 ◽  
Author(s):  
Nóra Bagdi ◽  
Melinda Magdus ◽  
E. Leidinger ◽  
Judith Leidinger ◽  
K. Vörös
Keyword(s):  
Blood Transfusion ◽  
Blood Group ◽  
Diagnostic Method ◽  
Type A ◽  
Blood Groups ◽  
Blood Type ◽  
Type B ◽  
Blood Types ◽  
Type Ab ◽  
Transfusion Reactions

Feline blood group determination is done as a routine diagnostic method in numerous countries. Blood transfusion reactions and feline neonatal isoerythrolysis (FNI) can be avoided with the identification of different feline blood groups. The present study is the first investigation in Hungary during which 100 cats have been examined from all over the country. These cats were out of six breeds: European domestic shorthair, Persian mix, Persian, Abyssinian, Siamese and British shorthair. In the Hungarian feline population European domestic shorthair are most common but other breeds also occur. European domestic shorthair, Persian mix, Abyssinian, Siamese and British shorthair individuals all belonged to blood type A (100%). Blood type B was found very rarely and only in Persian cats. One-third of the Persian cats were categorised into blood type B, whilst type AB was not found during the study.

Maternal ABO Blood Group Type B: A Risk Factor in the Development of Neonatal Group B Streptococcal Disease

PEDIATRICS ◽  
1978 ◽  
Vol 62 (4) ◽  
pp. 504-509
Author(s):  
Joan A. Regan ◽  
Solan Chao ◽  
L. Stanley James
Keyword(s):  
Blood Group ◽  
Receptor Site ◽  
Blood Type ◽  
Abo Blood Group ◽  
Type B ◽  
Group B Streptococci ◽  
Group Type ◽  
Increased Risk ◽  
Blood Group Type ◽  
Group B

In a prospective study of maternal genital colonization with group B streptococci (GBS) at the time of delivery, epidemiological data, including blood type (ABO group), were recorded for the 1,062 patients studied. Blood type B was found in a statistically significant higher proportion of patients colonized with CBS (28%) compared with the total population (16.4%) (P &lt; .005, x2 = 8.43). Women with blood type B were twice as likely to be colonized as those with types 0 or A. Hypotheses to explain this observation include the possibilities that GBS possess a B-like antigen, rendering parturients who lack anti-B antibody at increased risk for GBS colonization, or that GBS possess a receptor site for B surface antigens. One may speculate that a mutation toward an affinity for the human ABO blood group type B accounts for the advent of the group B Streptococcus as a significant perinatal pathogen.

ABO blood group and the risk of lung cancer: Multicenter, case-control, observational study.

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. 1596-1596
Author(s):  
Gungor Utkan ◽  
Yuksel Urun ◽  
Ayten Kayi Cangir ◽  
Omur Berna Oksuzoglu ◽  
Nuriye Özdemir ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Blood Group ◽  
Clinical Features ◽  
Blood Type ◽  
Control Group ◽  
Abo Blood Group ◽  
Significant Difference ◽  
Abo Blood Type ◽  
Relationship Of

1596 Background: The role of genetic factors in the development of cancer is widely accepted. Previous studies have observed an association between ABO blood group and risk of certain malignancies, including pancreatic and gastric cancer. The data on the role of ABO blood group and Rh factor in lung cancer is limited. Methods: All patients who had Lung cancer (LC) and treated between 2000-2011 at the involved centers with defined ABO/Rh were included in our retrospective reviews of tumor registry records. A group of volunteer healthy blood donors of Turkish Red Crescent between 2004 and 2011 were identified as a control group. The relationship of ABO/Rh with clinical features such as age at diagnosis, histological subtype and sex were evaluated. We compared the distributions of ABO/Rh among 1954 patients and 3,022,883 controls. Among LC patients, differences between each of aforementioned ABO/Rh groups with respect to various clinical features were explored, respectively. Results: Of these patients the median age was 62 (range: 17-90). The 84% of patients were male. Overall distributions of ABO blood groups as well as Rh factor were statistically different between patients (43.6% A, 8.3% AB, 17.3% B, 30.8% O, and 86.3% Rh+) and controls (42.2% A, 7.6% AB, 16.3% B, 33.9% O, and 87.7% Rh+) (p=0,03). In addition, there were statistically significant differences between patients and controls with respect to O vs. nonO (p=0.004) and marginal significance for A vs. nonA (p=0,065), B vs. nonB (p=0,076), and Rh+ vs. Rh- (p=0,057). Among patients, there weren’t statistically significant differences between blood group with respect to sex and age. However there was statistically significant difference between blood group with respect to histology (p=0,001). Although the distribution of A and O were similar according to histology, patients with squamous histology had antigen B more frequently than other histological sub types (p=0,009). Conclusions: In the study populations, ABO blood type was statistically significantly associated with the LC and having blood type other than O increases the risk of LC. Further studies are necessary to define the mechanisms by which ABO blood type may influence breast cancer risk.

ABO blood group and risk of lethal prostate cancer.

2014 ◽  
Vol 32 (4_suppl) ◽  
pp. 69-69 ◽  
Author(s):  
Yuksel Urun ◽  
Kathryn M Wilson ◽  
Irene M. Shui ◽  
Edward L. Giovannucci ◽  
Brian M. Wolpin ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Blood Group ◽  
Specific Antigen ◽  
Cox Proportional Hazards ◽  
Blood Type ◽  
Abo Blood Group ◽  
Increased Risk ◽  
Abo Blood Type ◽  
Lethal Prostate Cancer

69 Background: An individual’s blood group is defined by variability in glycotransferases expressed on red blood cell surface; these ABO antigens are also highly expressed on epithelial cells. Previous studies have suggested associations between ABO blood group and increased risk of epithelial cancers including gastric, pancreatic, and ovarian; however, its relationship with risk of prostate carcinoma, and its aggressiveness remains unclear. Methods: We prospectively evaluated the association between ABO blood group and risk of lethal prostate cancer in the Health Professionals Follow-up Study (HPFS) from 1996 to 2008. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using Cox proportional hazards models with adjustment for other risk factors and prostate-specific antigen testing. Results: During 12 years of follow-up of 26,602 men, 2,703 cases of incident prostate cancer were documented, including 289 lethal cases (prostate cancer death or distant metastases). The frequency of ABO blood type was similar between men who developed prostate cancer (37% A, 7% AB, 13% B, and 43% O) and other participants (37% A, 8% AB, 12% B, and 43% O). On multivariate analysis, blood type was not associated with overall prostate cancer incidence. However, compared to men with blood group O, those with blood group AB were significantly less likely to develop lethal prostate cancer (multivariate-adjusted HR = 0.39 [95% confidence interval {CI} = 0.18-0.85]). There was no association between type B or A compared to O with lethal disease. ABO blood type was not significantly associated with the risk of advanced stage or high-grade cancers (Gleason score 8 to 10). Conclusions: Blood group AB was associated with a lower risk of lethal prostate cancer compared to blood group O. Further studies are needed to replicate these findings and to clarify possible biological mechanisms underlying this association.

Sign in / Sign up

Export Citation Format

Share Document